tetanus toxoid
PolandDrugs containing this active substance
-
The vaccine is used to boost protection against diphtheria, tetanus, and pertussis (whooping cough). It protects against diseases caused by the specific bacteria it is targeted against.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid not less than 2 IU (2 Lf)/0.5 ml tetanus toxoid not less than 20 IU (5 Lf)/0.5 ml pertussis antigens pertussis toxoid 2.5 mcg, filamentous hemagglutinin 5 mcg, pertactin 3 mcg, fimbriae type 2 and 3 5 mcg/0.5 ml ATC: J07AJ52
Manufacturer: Sanofi Winthrop Industrie Sanofi-Aventis Zrt.
-
The vaccine is used to strengthen protection against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It is used in children from 3 years of age, adolescents, and adults after a full course of primary vaccinations.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid Not less than 2 IU (2 Lf) tetanus toxoid Not less than 20 IU (5 Lf) pertussis toxoid 2.5 mcg fibrillar hemagglutinin 5 mcg pertactin 3 mcg fimbriae (type 2 and 3) 5 mcg inactivated poliovirus type 1 29 units of D3 antigen inactivated poliovirus type 2 7 units of D3 antigen inactivated poliovirus type 3 26 units of D3 antigen ATC: J07CA02
Manufacturer: Sanofi-Aventis Zrt.
-
The vaccine is used to prevent diphtheria, tetanus, and pertussis (whooping cough). It helps the body develop its own immunity to these three diseases.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided ATC: J07AJ52
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). It helps the body develop immunity to these four diseases.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid > or equal to 2 IU (2.5 Lf) aluminum phosphate 0.2 mg Al 3+ inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D tetanus toxoid > or equal 20 IU (5 Lf) aluminum hydroxide hydrate 0.3 mg Al 3+ bordetella pertussis antigens 8 mcg + 8 mcg + 2.5 mcg ATC: J07CA02
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is used to protect against tetanus and diphtheria. After administration of the preparation, the body produces antibodies that protect against these diseases.
Form: suspension for injection
Active substance Dosage diphtheria toxoid ad 10 ml tetanus toxoid not less than 40 IU ATC: J07AM51
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used to immunize children against diphtheria and tetanus.
Form: suspension for injection
Active substance Dosage tetanus toxoid not less than 40 IU diphtheria toxoid not less than 30 IU ATC: J07AM51
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The DTP vaccine protects against diphtheria, tetanus, and pertussis.
Form: suspension for injection
Active substance Dosage diphtheria toxoid not less than 30 IU tetanus toxoid not less than 40 IU inactivated bordetella pertussis strain suspension not less than 4 IU ATC: J07AJ51
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
This is a vaccine used as a booster dose in children over 6 years of age, adolescents, and adults. It is used for the simultaneous prevention of diphtheria, tetanus, and poliomyelitis.
Form: suspension for injection
Active substance Dosage poliovirus type 1 mahoney strain inactivated 1,245 g/10 ml diphtheria toxoid 0.01 g/10 ml poliovirus type 2 mef-1 strain inactivated ad 1 ml tetanus toxoid 0.01 g/10 ml poliovirus type 3 sabin strain inactivated 32 units of antigen D ATC: J07CA01
Manufacturer: Sanofi Pasteur Sanofi-Aventis Ltd.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), poliomyelitis (polio), and infections caused by Haemophilus influenzae type b (Hib) in children.
Form: powder and suspension for preparation of injection suspension
Active substance Dosage diphtheria toxoid No input provided tetanus toxoid No input provided bordetella pertussis antigens No input provided inactivated poliovirus types 1, 2 and 3 No input provided haemophilus b polysaccharide conjugated with tetanus toxoid No input provided ATC: J07CA06
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is used to prevent diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio).
Form: suspension for injection
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D diphtheria toxoid or equal to 30 IU tetanus toxoid or equal to 40 IU pertussis antigens 25 mcg + 25 mcg + 8 mcg ATC: J07CA02
Manufacturer: GlaxoSmithKline Biologicals S.A.
-
The vaccine is intended to prevent invasive meningococcal disease caused by group C bacteria, which can cause severe infections such as meningitis or septicaemia.
Form: suspension for injection
Active substance Dosage tetanus toxoid 10 - 20 mcg polysaccharide (o-deacetylated) neisseria meningitidis group c (strain c11) 10 mcg ATC: J07AH07
Manufacturer: Pfizer Manufacturing Belgium NV
-
The vaccine helps protect children from 6 weeks of age against diphtheria, tetanus, pertussis, poliomyelitis, and invasive infections caused by Haemophilus influenzae type b (such as meningitis or septicaemia).
Form: powder and suspension for preparation of injection suspension
Active substance Dosage inactivated poliovirus type 1 40 units of antigen D inactivated poliovirus type 2 8 units of antigen D inactivated poliovirus type 3 32 units of antigen D haemophilus influenzae type b conjugated polysaccharide-tetanus toxoid conjugate 10 mcg diphtheria toxoid not less than 30 IU tetanus toxoid not less than 40 IU bordetella pertussis antigens 25 mcg + 25 mcg ATC: J07CA02
Manufacturer: Sanofi Winthrop Industrie
-
The vaccine provides protection against diphtheria, tetanus, and pertussis (whooping cough). It stimulates the body to produce antibodies against these bacteria.
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid Not less than 2 IU tetanus toxoid Not less than 20 IU pertussis toxoid 20 mcg ATC: J07AJ52
Manufacturer: AJ Vaccines A/S
-
It is used to protect against tetanus, a disease caused by Clostridium tetani bacteria. It helps the body produce antibodies that protect against infection.
Form: suspension for injection
Active substance Dosage tetanus toxoid not less than 40 IU ATC: J07AM01
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used to protect against tetanus, a disease caused by bacteria that can enter the body through wounds, cuts, or scratches.
Form: suspension for injection
Active substance Dosage tetanus toxoid 10 Lf (40 IU) ATC: J07AM01
Manufacturer: Institute of Biotechnology of Sera and Vaccines BIOMED S.A.
-
The vaccine is used to induce immunity against tetanus, a serious bacterial disease.
Form: suspension for injection
Active substance Dosage tetanus toxoid not less than 40 IU ATC: J07AM01
Manufacturer: Biomed Ltd., Manufacturer of Sera and Vaccines
-
The vaccine helps protect the child against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio).
Form: solution for injection in ampoule-syringe
Active substance Dosage diphtheria toxoid minimum 30 IU tetanus toxoid minimum 40 IU bordetella pertussis antigens 25 micrograms poliovirus type 1 mahoney strain inactivated 40 units of antigen D poliovirus type 2 mef-1 strain inactivated 8 units of antigen D poliovirus type 3 sabin strain inactivated 32 units of antigen D ATC: J07CA02
Manufacturer: Sanofi Winthrop Industry Sanofi Winthrop Industry Sanofi-Aventis Ltd.